For the first time ever we’re re-running an episode! Chris Hill explains why a solo episode from August 6, 2019 entitled “This is the business we’ve chosen” is making a return appearance.
In today’s healthcare focused episode, Motley Fool analysts Maria Gallagher and Emily Flippen discuss the prospects for 10x Genomics, a healthcare tech company looking to reform the way researchers discover single cell gene expression.
Matt Argersinger, senior advisor for Motley Fool Millionacres, joins us to talk about how Covid-19 has impacted residential and commercial real estate and offers his advice for homeowners and investors going forward.
Microsoft buys Nuance Communications in a $16 billion deal. Coinbase makes an $86 billion Wall Street debut. FDA hits the pause button on Johnson & Johnson’s COVID-19 vaccine. Katrina Lake steps down as the CEO of Stitch Fix. Bed Bath & Beyond slips on earnings. White Claw introduces Surge. Pepsi serves up big growth in its snack division. And IBM unveils a surprising name for its cloud business. Motley Fool analysts Emily Flippen and Ron Gross discuss those stories and share two stocks on their radar: Bilibili and Ecolab. Plus, e.l.f. Beauty CFO Mandy Fields talks about the big business of cosmetics.
Today we review 5 Stocks for the Coronavirus, 5 Stocks For The Age of Miracles, and 5 Stocks I Own That You Should Too. Spoiler alert: one of these is not like the others! But do we beat the efficient market? Yes. Indeed we do.
What Business Are You In?
For the first time ever we’re re-running an episode! Chris Hill explains why a solo episode from August 6, 2019 entitled “This is the business we’ve chosen” is making a return appearance.
Apr 21, 2021 • 15:33 • Market Foolery
Listen